The shares of The Meet Group, Inc. (NASDAQ:MEET) has performed poorly over the past three months, as it lost around -0.35% while it has so far climbed around 25.22% during the course of a year. It went down by -$0.28 now trading at $4.24. Their shares witnessed a 130.43% increase from the 52-week low price of $1.84 they recorded on 2018-04-04. Even though it is still -32.78% behind the $5.63 high touched on 2018-10-08. The last few days have been rough for the stock, as its price has decreased by -3.74% during the week. The stock of MEET recorded 50.53% uptrend from the beginning of this year till date. The 12-month potential price target for The Meet Group, Inc. is set at $6.58. This target means that the stock has an upside potential to increase by 55.19% from the current trading price.
When giving their opinion, around 100% of Wall Street analysts, which represents 3 out of 3 rated the stock as a Buy. 0 brokerage firms of the remaining 0% rated the stock as a Hold with 0 analyst rating it as a sell. Overall, the number of aggregate MEET shares held by institutional investors represents 56% of total shares. 24 institutions entered new The Meet Group, Inc. (NASDAQ:MEET) positions, 62 added to their existing positions in these shares, 42 lowered their positions, and 16 exited their positions entirely.
The Meet Group, Inc. (MEET) trade volume has increased by 159.36% as around 2,344,470 shares were sold when compared with its 50-day average volume of traded shares which is 903,934. At the moment, MEET is witnessing a downtrend, as it is trading -5.61% below its 20-day SMA, -11.17% below its 50-day SMA, and 17.03% below its 200-day SMA. The company runs an ROE of roughly -34.9%, with financial analysts predicting that their earnings per share growth will be around 20% per annum for the next five year. This will be compared to the -35.4% decrease witnessed over the past five years.
The first technical resistance point for The Meet Group, Inc. (NASDAQ:MEET) will likely come at $4.8, marking a 11.67% premium to the current level. The second resistance point is at $5.35, about 20.75% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $3.25, the lower end of the range. MEET’s 14-day MACD is 0.09 and this positive figure indicates an upward trading trend. The company’s 14-day RSI (relative strength index) score is 40.59, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 47 percent, which is low when compared to that of the 50-day’s 52.87 percent.
The shares of Express Scripts Holding Company (NASDAQ:ESRX) has increased by 1.31%, and now trading at $99.48 on the Wall Street in the intra-day deal, with their shares traded now around 5,092,252. This is a rise of 1,184,804 shares over the average 3,907,448 shares that were traded daily over the last three months. The stock that is trading at $99.48 went higher by 68.13% from its 52-week low of $59.17 that it attained back on 2017-11-14. The stock recorded a 52-week high of $100.43 nearly 1 days ago on 2018-11-07.
ESRX stock has performed well over the past 30 days, as it added 3.09% while its price climbed by 33.28% year-to-date (YTD). Looking at the last few days, it has been good for the stock, as it rose 2.59% over the last week. The stock’s 12-month potential target price is now at $91.31. This means that the stock price might likely increase by -8.21% from its current trading price.5 out of 19 Wall Street analysts which represents 26.32% rated the stock as a buy while the remaining 73.68 rated it as a hold, with 0 of analysts rating it as a sell.
Express Scripts Holding Company (NASDAQ:ESRX) has been utilizing an ROE that is roughly 25.6%, with stock analysts predicting that the company’s EPS for the next five years will go up by 12.23% per year, following the 41.2% raise that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 4.23% above its 20-day SMA, 6.09% above its 50-day SMA, and 22.67% above its 200-day SMA. In percentage terms, the aggregate Express Scripts Holding Company shares held by institutional investors is 86.5%. 106 institutions jumped in to acquire Express Scripts Holding Company (ESRX) fresh stake, 416 added to their current holdings in these shares, 566 lowered their positions, and 87 left no stake in the company.
The stock’s 9-day MACD is 1.64 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 69.92, which shows that its stock has been overbought. The 20-day historical volatility for the shares stand at 25.3 percent, which is more when compared to that of the 50-day’s 20.09 percent. On the daily chart, we see that the stock could reach the first level of resistance at $100.32, sporting a 0.84% premium to the current level. The next resistance point is at $101.16, representing nearly 1.66% premium to the current market price of Express Scripts Holding Company (ESRX). On the other hand, failure to breach the immediate hurdles can drag it down to $98.02, the lower end of the range.